Diseases which need operation under general anesthesia
Conditions
Interventions
conditions. Either inhalational anesthesia or TIVA is allowed. 2. Tracheal intubation is done after adequate dose of rocronium is injected. 3. Intraoperative rocuronium useage is determined by the
0.9, the reversal with sugammadex is considered once agein and the respiratory condition is checkd. When the reversal is done once again, another TOF ratio is measured.
Sponsors
Tokyo Neuromuscular Meeting
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients, aged 20 or over (ASA phisical status 1-3) and who is operated under general anesthesia using rocuronium as neuromuscular blocking agent and sugammadex as neuromuscular reversal agent.
Exclusion criteria
Exclusion criteria: Patients who have a history of hypersensitivity to rocuronium and bromide. Patients who have a history of hypersensitivity to sugammadex. Patients who have myasthenia gravis and myasthenic syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of patients whose TOF ratio <0.9 after tracheal extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Existence or nonexistence of pulmonary or other complication after surgery 2. Total rocuronium dose 3. Time from extubation to measurement of TOF ratio 4. Time from latest rocuronium use to extubation 5. Time from administration of sugammadex to extubation 6. The difference of TOF ratio among the ages and the anesthetic managements | — |
Countries
Japan
Outcome results
None listed